WHO Guidance for HVAC, Water and Utility Validation in Emerging Markets


Published on 16/11/2025

WHO Guidance for HVAC, Water and Utility Validation in Emerging Markets

The validation of utilities, including HVAC systems, water systems, and compressed gases, is an essential part of ensuring that pharmaceutical manufacturing adheres to Good Manufacturing Practices (cGMP). The World Health Organization (WHO) has provided extensive frameworks for these validations, particularly in emerging markets where there may be unique challenges. This article will delve into the regulatory expectations set forth by WHO regarding utilities validation, emphasizing key frameworks, lifecycle concepts, documentation practices, and inspection focus.

Understanding WHO Utilities Validation

Utilities validation refers to the systematic approach taken to ensure that utilities employed in pharmaceutical manufacturing consistently perform to required specifications and standards. This includes a range of systems, primarily Heating, Ventilation, and Air Conditioning (HVAC), water systems, and compressed gases. They are critical to maintaining environments suitable for product quality and safety.

The WHO has outlined specific expectations for conventional utilities validation in

their guidelines, highlighting the importance of risk assessment and the lifecycle approach. This means that every stage of a utility’s lifecycle—from design and qualification to operation and maintenance—must be meticulously documented and controlled.

This is particularly significant in emerging markets, where the infrastructure may be less established. Validation activities must therefore be adaptable without compromising compliance with global standards.

Regulatory Frameworks Influencing Validation Practices

The validation of utilities is primarily influenced by various global regulatory expectations. These include the WHO Guidance, US FDA guidance documents, EMA’s Annex 15, ICH Q8–Q11, and guidelines provided by PIC/S. Each of these frameworks contributes to a comprehensive understanding of the validation landscape.

The WHO’s guidelines particularly emphasize the necessity of having robust systems in place to assess the quality of water used in pharmaceutical processes. They stipulate that water systems must be validated to ensure suitability for the intended purpose, aligning with the principles laid out in WHO TRS 965 and other associated documents.

On the other hand, the FDA provides expectations through their Process Validation Guidance, which states that the validation lifecycle should encompass stages of development, performance qualification, and ongoing monitoring. In achieving consistency, organizations are encouraged to adopt a risk-based approach, aligning closely with ICH Q9 principles of Quality Risk Management.

Key Components of the Utilities Validation Lifecycle

The lifecycle of utilities validation comprises multiple phases: Design Qualification (DQ), Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). Each of these phases plays a crucial role in ensuring that all utilities meet specified performance criteria.

Design Qualification (DQ)
DQ is the initial stage in which the design of the utility system is assessed against predefined requirements. This ensures the system is designed to function in accordance with its intended purpose. For HVAC systems, critical parameters such as air exchange rates, temperature control, and humidity levels must be established at this stage.

Installation Qualification (IQ)
During IQ, the installation of systems is verified. This includes documenting equipment setup against specifications and ensuring that components are installed correctly. In many cases, this involves checks against manufacturer specifications and engineering drawings.

Operational Qualification (OQ)
Once installation is confirmed, OQ is performed to demonstrate that the utility operates as intended across its operating range. For water systems, testing may include verifying chemical parameters, microbial limits, and system performance under anticipated use conditions.

Performance Qualification (PQ)
Lastly, PQ requires validation through simulated production runs to demonstrate consistent performance under defined conditions. This stage confirms that the system maintains suitable conditions for pharmaceutical manufacturing over time.

Documentation Requirements in Utilities Validation

Comprehensive documentation is a cornerstone of utilities validation, serving to demonstrate compliance with regulatory requirements. Documentation should be clear, detailed, and accessible for inspections. The following are essential documents to be maintained:

  • Validation Plans: Outlining the strategy, resources, and timelines involved in the validation process.
  • Protocols: Detailed methods for executing each phase of validation, including acceptance criteria.
  • Reports: Summaries of findings from DQ, IQ, OQ, and PQ activities, alongside deviations and resolutions.
  • Change Control Records: Documentation of any changes made to systems or processes that could affect validation status.
  • Training Records: Evidence that personnel involved in validation activities have received appropriate training.

In addition to maintaining the above documentation, it is essential to ensure that it remains up-to-date throughout the lifecycle of the utilities. This includes regular reviews and revisions as necessary, particularly when there are significant changes to the utility systems or regulatory guidelines.

Inspection Focus Areas for WHO Utilities Validation

Regulatory inspections play a critical role in validating compliance with WHO guidelines. Inspectors focus on several key areas during their assessment of utilities validation.

Compliance with Validation Protocols: Inspectors will evaluate whether organizations adhere to their documented validation protocols and whether the protocols align with regulatory expectations.

Effectiveness of Risk Management: The ability of organizations to implement a risk-based approach, particularly the identification, assessment, and mitigation of risks associated with utility systems will be scrutinized. Inspectors will want to see substantial evidence of risk assessments performed at various stages of the utilities validation lifecycle.

System Performance: A major focus will be on the validated performance of utilities as demonstrated through evidence from PQ activities. Inspectors will verify that systems consistently operate within required parameters and provide for the safety and quality of products.

Concluding Thoughts on WHO Utilities Validation in Emerging Markets

In summary, the validation of utilities such as HVAC, water systems, and compressed gases is paramount to ensuring compliance with global cGMP standards. Regulatory expectations outlined by the WHO, FDA, EMA, and other bodies, emphasize a structured approach that encompasses the entire lifecycle of the utility systems, from initial design through to ongoing performance monitoring. In emerging markets, it is critical to adapt these standards while ensuring that quality assurance remains a priority. Through proper documentation, adherence to risk-based strategies, and focused inspection practices, pharmaceutical companies can effectively navigate the complexities of utilities validation and ultimately ensure product quality and patient safety.